Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2023 $ (6,403) $ 135 $ 454,759 $ (461,298) $ 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Issuance of ordinary shares, net 7,217 $ 30 7,187    
Issuance of ordinary shares, net (in shares)   2,971,411      
Share-based compensation expense 138   138    
Net loss (7,101)     (7,101)  
Unrealized gain on available-for-sale securities (1)       (1)
Ending balance at Mar. 31, 2024 (6,150) $ 165 462,084 (468,399) 0
Ending balance (in shares) at Mar. 31, 2024   16,470,414      
Beginning balance at Dec. 31, 2023 (6,403) $ 135 454,759 (461,298) 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Net loss (24,774)        
Ending balance at Dec. 31, 2024 (4,081) $ 315 481,676 (486,072) 0
Ending balance (in shares) at Dec. 31, 2024   31,534,233      
Issuance of ordinary shares, net 6,325 $ 42 6,283    
Issuance of ordinary shares, net (in shares)   4,125,901      
Exercise of warrants for ordinary shares, net (in shares)   26,482      
Exercise of warrants for ordinary shares, net 32   32    
Share-based compensation expense 61   61    
Net loss (4,891)     (4,891)  
Ending balance at Mar. 31, 2025 $ (2,554) $ 357 $ 488,052 $ (490,963) $ 0
Ending balance (in shares) at Mar. 31, 2025   35,686,616